The company fully deploys 2018 work
Release time:
2020-07-31
News from our newspaper 1# April 27 , the group company held a business work analysis meeting to review and summarize the work situation in 2017 , arrange and deploy the work for the new year, and put forward the work requirements. At the
meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2017 , focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and the work plan for 2018 . Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017 . Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of
Group Company, made a comprehensive review of the company's operation in 2017 , made a comparative analysis of the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, and improving the ability of fund management and tax planning, scientific and technological innovation and technological transformation have achieved certain results, marketing management and market expansion have been strengthened, safety and environmental protection work has basically reached the standard, training and talent development have achieved new results and other work highlights; at the same time, strategic decision-making, management innovation, performance appraisal, market operation, and talent team building Summarize and reflect on the shortcomings in other aspects. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong notified the benefit targets of various professional companies and directly affiliated enterprises in 2018 , and proposed to formulate new plans, promote new development, and seek new profit growth points; Continue to promote management innovation and further optimize management organization; strengthen technological innovation and improve the development system; innovate marketing management and comprehensively improve marketing capabilities; strengthen human resource management, strengthen the construction of talent team; promote safety and environmental protection management to a higher level; further strengthen the construction of corporate culture and other seven key tasks. In his concluding speech, Jiang Xiaomeng, chairman of
Group Company, expressed his affirmation and gratitude to all enterprises for their efforts and achievements in 2017 . For future work, he hoped that the heads of subordinate enterprises must seriously consider the four major issues of product structure adjustment, new product development direction, cultivation of well-known brands and improvement of product added value, efforts should be made to do a good job in the five aspects of environment, talents, strategy, culture and management. Jiang Xiaomeng pointed out that marketing ability is the first productive force of an enterprise, innovation ability is the development ability of an enterprise, cost control ability is the competitiveness of an enterprise, cultural ability is the vitality of an enterprise, and salary level is the attraction of an enterprise. If an enterprise wants to do a good job, it must strive to enhance its five abilities. Jiang Xiaomeng also put forward requirements on how to further realize high-quality development, how to recognize risks and opportunities, product research and development, talent introduction, effective incentives, strengthening organizational leadership and other specific work. He hoped that cadres and employees at all levels would focus on the core of their work, pay attention to the key points, improve their abilities, create new prosperity, and hand in a satisfactory answer for the 33rd anniversary of peak entrepreneurship 60. (Reporter Fu Yiwu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31